drugset / Trial / NCT00584155
Protection From Cisplatin Ototoxicity by Lactated Ringers
RandomizedSingle-groupSingle-blindTreatment
Summary
The purpose of this study is to determine if Lactated Ringer's solution is effective in patients undergoing chemotherapy with cisplatin for head and neck cancer in regards to cisplatin-induced hearing loss.
Timeline
- Start
- 2006-07
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ringer's Lactate | Other / unclassified | — | Other |
| Background | Ofloxacin | Small molecule | 0.03 % | Other |
| Background | Ofloxacin | Small molecule | 0.3 % | Other |